Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

WHO’s Nod Can’t Mask Ocugen’s Flimsy Fundamentals

By Ian Bezek, InvestorPlace Contributor
Ocugen has been trying to commercialize a Covid-19 vaccine. However, many obstacles remain. Meanwhile, insiders are dumping OCGN stock.

Blackberry Has a Grim Future Ahead as the Meme Mirage Fades

By Muslim Farooque, InvestorPlace Contributor
BB stock has minimal growth catalysts and dismal financial flexibility to turnaround its fortunes. Blackberry's future is dim.

Moderna Stock Could Have a Lot Further to Fall After Disasterous Earnings

By Joel Baglole, InvestorPlace Contributor
Over the last five trading sessions, Moderna's stock has cratered 30%, dropping from $350 a share all the way down to $240. The steep fall came after the Cambridge, Massachusetts-based company reported disappointing quarterly results that shocked Wall Street and revised down its forward guidance.

Palantir: The Perils of Extremism

By Dana Blankenhorn, InvestorPlace Contributor
Palantir is funding 10 start-ups to prove the value of its proprietary software in commercial markets. But it's rejecting the course of the industry.

AMC Stock Is Running Out of All That Time It Borrowed

By Dana Blankenhorn, InvestorPlace Contributor
AMC is not a growth stock. It's a retailer, worth $5 on a good day. The market cap entering November 9 was $23 billion.

3 Sorry Stocks That You Should Dump Before Year-End

By Joel Baglole, InvestorPlace Contributor
Not all stocks are created equal. While many securities have enjoyed spectacular runs this year, others have struggled and fallen steeply - underperforming the S&P 500 index's year-to-date gain of 25%. As we come to the end of 2021, it is a good time for investors to review their portfolio with an eye to culling the underperforming stocks and reallocating capital to winning securities.

Skip ContextLogic as Its Revenue Continues to Decline

By Alex Sirois, InvestorPlace Contributor
WISH stock was supposed to be a great e-commerce disruptor, but its weak business model is leading to decreasing revenues.

7 F-Rated Stocks to Sell Before We Reach Christmas

By Louis Navellier and the InvestorPlace Research Staff
It's just as important to know what stocks to sell as it is to know what stocks to buy. These stocks are prime examples of stocks to drop now.

Upstart Stock Has a Valuation Issue That Eclipses Any Upside Thesis

By David Moadel, InvestorPlace Contributor
UPST stock seems to have gotten ahead of itself, but patient investors can wait as the AI-powered fintech company definitely has potential.

Carnival Corporation Stock May Be Turning Around, But Value Investors Should Stay Away

By Muslim Farooque, InvestorPlace Contributor
CCL stock is likely to be weighed down by Carnival's substantial debt load and unimpressive sales

Google Is Never Going to Buy BlackBerry

By Will Ashworth, InvestorPlace Contributor
BlackBerry continues losing money. Yet BB stock is up almost 66% in 2021. Is there something I’m missing about its business? I don’t think so. 

Cassava Is a Sell After Accusations of Data Manipulation

By Larry Ramer, InvestorPlace Contributor
After Cassava was accused of multiple improprieties for its star Simufilam drug, investors should sell the vast majority of their SAVA stock.

Affirm Stock May Have a Bright Future, But It Is Already Priced In

By Larry Ramer, InvestorPlace Contributor
Facing very tough competition and losing a great deal of money, Affirm is not an appealing name. Investors should sell AFRM stock.

Ocugen Stock Looks Poised to Take a Tumble Right Here

By Larry Ramer, InvestorPlace Contributor
After WHO granted Covaxin a limited Emergency Use Listing, many institutions and hedge funds are likely to sell or short OCGN stock.

Lucid Stock Has a Frightening Valuation on Only a Little Good News

By GS Early
EVs are starting to ramp up now from both the upstarts and the big automakers. It's an exciting time, and LCID stock offers its own thrills.

Microvision Is Almost Indefensible After This Awful Earnings Surprise

By David Moadel, InvestorPlace Contributor
MVIS stock plunged after the company revealed some dreadful fiscal stats - and just because the stock is lower, doesn't mean that it's a buy.

With Ocugen Stock: Follow The Lead of Traders and ‘Sell The News’

By Thomas Niel, InvestorPlace Contributor
With its chances of experiencing another sharp slide in price likely. If you own OCGN stock today, cash out ASAP to avoid holding the bag. If you don't own it? Avoid at all costs.

Massive Jump Is a Great Selling Opportunity For Novavax Stock

By Josh Enomoto, InvestorPlace Contributor
Although NVAX stock has recently been bolstered by good news, it may not be enough to overcome vaccine disinformation.

UBER Stock Doesn’t Look as If It Will Rebound Anytime Soon

By Joel Baglole, InvestorPlace Contributor
The only question left regarding shares of Uber Technologies is: where's the bottom? At $43.11 per share, the San Francisco-based ride hailing and food delivery company's stock is now down 33% from its 52-week high of $64.05. Uber stock has fallen 21% in the past six months, including a 6% decline in the last month.
Load More Articles